Fuso Pharmaceutical Industries,Ltd.

Tokyo Stock Exchange 4538.T

Fuso Pharmaceutical Industries,Ltd. Cash and Short-Term Investments for the year ending March 31, 2024: USD 33.83 M

Fuso Pharmaceutical Industries,Ltd. Cash and Short-Term Investments is USD 33.83 M for the year ending March 31, 2024, a -43.92% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Fuso Pharmaceutical Industries,Ltd. Cash and Short-Term Investments for the year ending March 31, 2023 was USD 60.32 M, a -0.06% change year over year.
Fuso Pharmaceutical Industries,Ltd. Cash and Short-Term Investments for the year ending March 31, 2022 was USD 60.36 M, a -5.51% change year over year.
Fuso Pharmaceutical Industries,Ltd. Cash and Short-Term Investments for the year ending March 31, 2021 was USD 63.88 M, a -5.48% change year over year.
Fuso Pharmaceutical Industries,Ltd. Cash and Short-Term Investments for the year ending March 31, 2020 was USD 67.59 M, a 30.87% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Tokyo Stock Exchange: 4538.T

Fuso Pharmaceutical Industries,Ltd.

CEO	Mr. Mikio Toda
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	1-7-10, Doshomachi
Employees	1,370
Sector	Consumers Staples
Industries Cleaning Supplies Automotive Parts Composite Materials Hardware & Electronics Non-Alcoholic Beverages Personal Care Pharmaceuticals Plastics

Description

Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such as injectables and artificial kidney dialysates; and medical machinery and equipment. It also rents real estate properties. The company was founded in 1937 and is headquartered in Osaka, Japan.

Key trends

Past 5 years